Pilot Configuration
Pilot Phase (Scoped Evaluation)
Up to 12 weeksTypical scope: multi-country, weekly updates, multiple categories
- Real data from real sources
- Live dashboards or export feeds
- Validate scope, refresh cadence, quality
- Fixed price, no ongoing commitment
Most teams start here to validate fit before expanding.
Now, schedule a short call below to confirm scope and start the pilot, or build something new.
or email us at paul@jsonify.co
Data sources are the websites and apps where information will be collected from. These can be changed or expanded at any time. This is turned into data rows.
| id | Source | Metric | Value | Indicator | Period | Geography | Trend | Last Updated | Notes | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
|
All-cause mortality rate (per 100k) |
|
Mortality | 2026-02-01 to 2026-02-03 | United States | ↑ 2.1% vs prior week | Feb 3, 2026 | Preliminary weekly provisional data; increases concentrated in Midwest and Northeast | ||
| 2 |
|
Respiratory syncytial virus (RSV) hospitalizations | 14,200 | Morbidity | 2026-01-25 to 2026-01-31 | Global (reported countries) | ↑ accelerating | Feb 2, 2026 | Surge in pediatric admissions reported across Europe and parts of Asia | ||
| 3 |
|
New Alzheimer’s clinical trial enrollments | 1,350 | Research activity | 2026-01-27 to 2026-02-02 | United States | ↔ stable | Feb 3, 2026 | Enrollment pace steady; several multisite trials added sites in Q1 | ||
| 4 |
|
Opioid overdose ED visits (count) | 6,430 | Morbidity | 2026-01-28 to 2026-02-03 | Selected US states reporting | ↓ 4.8% vs prior week | Feb 3, 2026 | Data aggregated from participating state dashboards; synthetic opioids remain majority | ||
| 5 |
|
Employer-sponsored insurance premium change (avg) | $612.00 | Cost | 2026 calendar Q1 estimate | United States | ↑ 3.3% YoY | Feb 2, 2026 | KFF analysis of employer contributions and carrier filings | ||
| 6 |
|
Global vaccine market value | $79.6B | Market size | 2025 full year | Global | ↑ 5.6% YoY | Feb 1, 2026 | Includes pediatric and adult immunization revenue across manufacturers | ||
| 7 |
|
Insurer COVID-19 claims frequency | 0.9% | Claims | 2026-01-01 to 2026-01-31 | United States | ↓ 12% MoM | Feb 3, 2026 | NAIC quarterly filing extract; includes commercial and Medicare supplemental | ||
| 8 |
|
Medical device recalls (count) | 28 | Safety | 2026-01-30 to 2026-02-03 | United States | ↑ from prior week | Feb 3, 2026 | Class II and III recalls; several software-related notices | ||
| 9 |
|
Years of life lost (YLL) — ischemic heart disease | 23,400,000 | Burden | 2025 annual estimate | Global | ↔ minimal change YoY | Feb 1, 2026 | IHME GBD recalibration; small method change vs 2024 | ||
| 10 |
|
Telehealth consults for mental health (weekly) | 42,800 | Service utilization | 2026-01-27 to 2026-02-02 | US Mayo network | ↑ 6% vs prior week | Feb 3, 2026 | Rise driven by university-age referrals and seasonal affective disorders | ||
| 11 |
|
Peer-reviewed COVID-19 long-term sequelae articles published | 9 | Research output | 2026-01-30 to 2026-02-03 | International authorship | ↑ publishing spike | Feb 3, 2026 | Focus on cardiovascular and neurocognitive long-COVID outcomes | ||
| 12 |
|
New commercial insurer plan entries (state-level) | 7 | Market competition | 2026 Q1 filings (late Jan to early Feb) | California, Texas, Florida, NY (varied) | ↑ modest | Feb 3, 2026 | Regional carriers expanding narrow-network plans; rate filings pending approval | ||
| 13 |
|
Influenza-like illness (ILI) activity level | Moderate | Surveillance | 2026-02-01 to 2026-02-07 | US National | ↑ increasing | Feb 3, 2026 | Elevated ILI in pediatric age groups; vaccine effectiveness early estimate pending | ||
| 14 |
|
International Health Regulations (IHR) alerts issued | 3 | Regulatory/alert | 2026-01-29 to 2026-02-03 | Global | ↔ constant | Feb 3, 2026 | Alerts related to novel influenza clusters and regional hemorrhagic fever reports | ||
| 15 |
|
NIH extramural grants awarded — infectious disease | $124.5M | Funding | FY2026 Q1 allocations | United States | ↑ compared with FY2025 Q1 | Feb 2, 2026 | Emphasis on pathogen surveillance and variant preparedness | ||
| 16 |
|
Vaccination clinic visits (COVID boosters) | 118,940 | Service utilization | 2026-01-25 to 2026-01-31 | US aggregated reporting | ↓ 9% vs prior week | Feb 2, 2026 | Lower uptake following holiday campaign; mobile clinics targeting seniors ongoing | ||
| 17 |
|
Medicaid enrollment change (monthly) | +62,300 | Coverage | 2026-01 | United States | ↑ 0.4% MoM | Feb 3, 2026 | State reports show modest growth in expansion states | ||
| 18 |
|
Average monthly premium — individual ACA plans | $453.67 | Cost | 2026 Q1 average | United States | ↑ 2.5% YoY | Feb 1, 2026 | Weighted average across silver plans in major exchanges | ||
| 19 |
|
Life insurer reserve stress test — solvency ratio median | 312% | Financial health | 2026 Q1 stress run | United States | ↔ stable | Feb 3, 2026 | Median of participating carriers after interest-rate stress scenarios | ||
| 20 |
|
Emergency use authorizations (EUA) issued this week | 1 | Regulatory action | 2026-01-31 to 2026-02-03 | United States | ↔ single event | Feb 3, 2026 | EUA for rapid multiplex respiratory pathogen panel | ||
| 21 |
|
DALYs attributable to air pollution | 135,800,000 | Burden | 2025 annual estimate | Global | ↓ small improvement YoY | Feb 1, 2026 | Declines concentrated in high-income settings with policy interventions | ||
| 22 |
|
Post-operative infection rate (orthopedics) | 0.8% | Quality | 2025 calendar year | Mayo Clinic network (US) | ↓ improvement | Feb 3, 2026 | Enhanced perioperative protocols credited for decline | ||
| 23 |
|
Systematic reviews on diabetes management published | 4 | Research output | 2026-01-28 to 2026-02-03 | International | ↔ steady | Feb 3, 2026 | Meta-analyses include SGLT2 inhibitor outcomes and CGM adoption | ||
| 24 |
|
Average small-group health plan premium change | $38.50/month | Cost change | 2026 Q1 filings | United States (average) | ↑ 4.2% YoY | Feb 3, 2026 | Rate filings cite provider cost inflation | ||
| 25 |
|
Suicide ideation ED visit rate (per 100k) |
|
Morbidity | 2026-01-24 to 2026-01-30 | US adolescent (12-17) | ↑ 3.5% vs prior week | Feb 2, 2026 | Mental health service referrals increasing; regional hotspots identified | ||
| 26 |
|
Antimicrobial resistance (AMR) surveillance reports submitted | 45 | Surveillance | 2026 Jan month-end | Member states reporting | ↑ reporting coverage | Feb 1, 2026 | Increased LMIC reporting after WHO capacity grants | ||
| 27 |
|
Published preclinical studies on pan-coronavirus vaccines | 6 | Research output | 2026-01-20 to 2026-02-03 | US and Europe | ↑ research activity | Feb 3, 2026 | Focus on broadly neutralizing antibody targets and nanoparticle platforms | ||
| 28 |
|
Hospital bed occupancy rate (acute care) | 78.6% | Capacity | 2026-02-01 to 2026-02-03 | US national aggregate | ↑ 1.9% vs prior week | Feb 3, 2026 | Higher occupancy in urban centers; elective procedure backlogs noted | ||
| 29 |
|
Percentage of adults delaying care due to cost | 14% | Access | 2026 Jan survey snapshot | United States | ↔ unchanged | Feb 2, 2026 | KFF brief based on monthly polling of adults | ||
| Looking for more? Great news − this is just a small sample. Jsonify production workflows process anywhere from tens of thousands to millions of real data rows per run! | |||||||||||
Filters
Total Emerging Risk Factors Identified
Competitive Policy Features Comparison
Average Morbidity Rate
Mortality Trends Over Time
Cumulative Mortality Rates by Year
Global Health Policy Changes Over Time
Morbidity Distribution by Condition
Recent Regulatory Filings
| Filing Date | Source | Type of Filing | Key Focus | Region |
|---|---|---|---|---|
| 2026-01-15 |
|
New Drug Application | Cardiovascular Disease | North America |
| 2026-01-20 |
|
Policy Update | Global Health Initiatives | Worldwide |
| 2026-01-25 |
|
Research Funding | Cancer Research | North America |
| 2026-01-30 |
|
Report Release | Health Insurance Trends | USA |
| 2026-01-28 |
|
Market Analysis | Telehealth Services | Europe |
| 2026-01-10 |
|
Data Update | Mortality Rates | Global |
| 2026-02-01 |
|
Industry Report | Risk Factors in Insurance | North America |
Source Contribution to Data Insights
Top 5 Emerging Health Risks
Key Observations on Risk Factors
Actuarial Report Highlights
| Risk Factor | Current Trend | Mortality Rate (%) | Source | Date |
|---|---|---|---|---|
| Obesity | Increasing |
|
|
2026-01-15 |
| Diabetes | Stable |
|
|
2026-01-20 |
| Cardiovascular Diseases | Increasing |
|
|
2026-01-25 |
| Mental Health Disorders | Increasing |
|
|
2026-01-15 |
| Cancer | Decreasing |
|
|
2026-01-10 |
| Respiratory Diseases | Stable |
|
|
2026-01-22 |
| Influenza | Increasing |
|
|
2026-01-30 |
Loading...
Loading...
Radar continuously monitors your selected web sources and alerts you the moment something changes.
+7
Data connections determine where the collected data will be delivered. You can add, remove, or change connections at any time.